A Technique to Generate a 2D Monolayer of Cerebellar Cells from Induced Pluripotent Stem Cells
JoVE Encyclopedia of Experiments
Neuroscience
0 views • 4:08 min • July 8th, 2025
Begin with human induced pluripotent stem cell colonies cultured on an adherent basement membrane matrix.
Add a cerebellar differentiation medium containing a specific hormone, growth factor, and small molecule inhibitors.
Lift the colonies using a glass pipette, and transfer them to an ultra-low attachment plate.
The low-attachment surface maintains the cells in suspension, facilitating their aggregation into three-dimensional embryoid bodies, or EBs.
The hormone, growth factor, and inhibitors bind to their respective target sites, promoting stem cell differentiation into neuronal progenitors.
Transfer the EBs to culture plate wells coated with a synthetic polymer and an adhesion protein to facilitate EB attachment.
Replace the medium with an inhibitor-free differentiation medium.
The cells begin to migrate outward from the EBs, forming a 2D monolayer.
Remove the medium and add a cerebellar maturation medium.
Growth factors in the medium induce the maturation of neuronal progenitors into distinct cerebellar neuronal precursors.
On day zero, add 1 milliliter of cerebellar differentiation medium supplemented with 10 micromolar Y27632 and SB431542 to each well of a six-well ultra-low attachment or ULA plate, and place it in the incubator until the lifted colonies are ready to be added to the wells. Clean the differentiated cells using a pulled glass pipette. Aspirate the medium, and add 1 milliliter of iPSC passaging solution for each 35-millimeter dish.
After three minutes of incubation at 37 degrees Celsius, aspirate the medium and add 2 milliliters of cerebellar differentiation medium supplemented with 10 micromolar Y27632 and SB431542. Under 4X magnification of a transmitted light-inverted microscope, lift the colonies using the bent edge of the pulled glass pipette. Once every colony is lifted, gently transfer all the colonies to one well of the 6-well ULA plate using a 10-milliliter serological pipette. Repeat this process for each iPSC plate, and incubate the cells at 37 degrees Celsius with 5% carbon dioxide.
On day 2, add FGF2 to each well to adjust a final concentration of 50 nanograms per milliliter. On day 7, change one-third of the medium by aspirating 1 milliliter of spent medium, and replacing it with 1 milliliter of fresh cerebellar differentiation medium. Incubate the embryoid bodies for seven days.
On day 14, swirl the plate to gather all the embryoid bodies in the center of the plate. Then, tilt the plate, and aspirate all the spent medium using a 1000-microliter pipettor from the edge. As the medium amount decreases, slowly lay the plate flat and continue to aspirate, leaving enough medium to avoid drying the embryoid bodies out.
Next, add 3 milliliters of fresh cerebellar differentiation medium supplemented with 10 micromolar. Y27632. Then, transfer the embryoid bodies using a 10-milliliter serological pipette to a poly-L-Ornithine laminin-coated dish. On day 15, aspirate the medium and replace it with fresh cerebellar differentiation medium.
Overview
This article details a protocol for differentiating human induced pluripotent stem cells (iPSCs) into cerebellar neuronal precursors. The method involves the use of specific growth factors and small molecule inhibitors to promote differentiation and maturation of the cells.
Key Study Components
Area of Science
- Neuroscience
- Stem Cell Biology
- Cell Differentiation
Background
- Human induced pluripotent stem cells can differentiate into various cell types.
- Cerebellar neurons play a crucial role in motor control and coordination.
- Specific growth factors and inhibitors are essential for guiding stem cell differentiation.
- Three-dimensional embryoid bodies (EBs) can enhance the differentiation process.
Purpose of Study
- To establish a reliable protocol for generating cerebellar neuronal precursors from iPSCs.
- To investigate the effects of various growth factors and inhibitors on neuronal differentiation.
- To optimize the culture conditions for the maturation of neuronal progenitors.
Methods Used
- Culture of iPSC colonies on an adherent basement membrane matrix.
- Use of cerebellar differentiation medium supplemented with specific hormones and inhibitors.
- Formation of three-dimensional embryoid bodies by transferring cells to ultra-low attachment plates.
- Sequential medium changes to promote differentiation and maturation of neuronal precursors.
Main Results
- Successful formation of embryoid bodies from iPSCs.
- Effective differentiation of EBs into cerebellar neuronal precursors.
- Observation of neuronal maturation in response to growth factor supplementation.
- Protocol demonstrates reproducibility and efficiency in generating neuronal cells.
Conclusions
- The described protocol provides a robust method for generating cerebellar neurons from iPSCs.
- Utilization of specific growth factors and inhibitors is critical for successful differentiation.
- This approach can be applied to study cerebellar development and related disorders.
Frequently Asked Questions
Executive Industry Relevance
Generating 2D monolayers of cerebellar cells from human iPSCs enables scalable, reproducible access to human neuronal subtypes for early discovery and disease modeling. This platform supports predictive confidence in target validation and mechanistic de-risking for neurodevelopmental and neurodegenerative research portfolios. The approach positions teams to bridge discovery biology with translational workflows using standardized, human-relevant systems.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of cerebellar developmental pathways in a controlled, human cell-based context.
- Supports functional target validation by generating glutamatergic and GABAergic neuronal precursors and Purkinje cell progenitors.
- Facilitates mechanistic de-risking by modeling human cerebellar differentiation in vitro.
Screening & Assay Development
- Provides a reproducible 2D monolayer amenable to quantitative phenotypic screening and compound evaluation.
- Standardizes differentiation and maturation steps for assay development and cross-lab reproducibility.
- Enables preparation of validated neuronal systems for downstream screening workflows.
Translational & Preclinical Research
- Aligns in vitro differentiation outputs with disease-relevant cerebellar cell types for translational biomarker studies.
- Supports continuity from early discovery through preclinical validation by enabling scalable production of human neuronal cells.
- Reduces translational risk by modeling human-specific developmental processes.
Pipeline & Workflow Integration
This differentiation protocol integrates into the discovery-to-preclinical continuum by providing a standardized source of human cerebellar cells for target validation, screening, and translational research.
- Discovery Biology: Supports hypothesis testing and pathway clarification in human neuronal development.
- Screening: Delivers assay-ready, reproducible monolayers for quantitative evaluation of compounds.
- Analytics: Enables measurement of neuronal differentiation and maturation using defined readouts.
- Translational Research: Bridges in vitro findings to preclinical models by generating disease-relevant cell types.
- Enterprise Reuse: Establishes a reusable, scalable platform for multiple neurobiological research programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in neuronal target validation.
- Operational Value: Standardizes differentiation and maturation protocols for reproducibility and scalability.
- Strategic Value: Improves go/no-go decision-making and capital efficiency by enabling early de-risking.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of neurobiological assets.
Implementation Considerations
- Requires expertise in stem cell culture and neuronal differentiation protocols.
- Needs access to specialized matrices, growth factors, and small molecule inhibitors.
- Demands cross-team standardization for reproducibility across discovery and screening groups.
- Adaptation may be needed for different iPSC lines or disease models.
- Limitations include the need for precise timing and quality control at each differentiation stage.
Biopharma FAQs
Deriving Retinal Pigment Epithelium (RPE) from Induced Pluripotent Stem (iPS) Cells by Different Sizes of Embryoid Bodies
Related Videos
0 Views
Streamlined 3D Cerebellar Differentiation Protocol with Optional 2D Modification
Related Videos
0 Views
Nerve Stem Cell Differentiation by a One-step Cold Atmospheric Plasma Treatment In Vitro
Related Videos
0 Views
Rapid and Efficient Generation of Neurons from Human Pluripotent Stem Cells in a Multititre Plate Format
Related Videos
0 Views
Generating Mature Cerebellar Organoids From Induced Pluripotent Stem Cells Using Single-Use Bioreactors
Related Videos
0 Views
Isolation of Stem Cells from Postnatal Mouse Cerebellum and Differentiation into Neural Cells
Related Videos
0 Views
Purification of Prominin-1+ Stem Cells from Postnatal Mouse Cerebellum
Related Videos
0 Views
Scalable Generation of Mature Cerebellar Organoids from Human Pluripotent Stem Cells and Characterization by Immunostaining
Related Videos
0 Views
2D and 3D Human Induced Pluripotent Stem Cell-Based Models to Dissect Primary Cilium Involvement during Neocortical Development
Related Videos
0 Views
Establishment of an Electrophysiological Platform for Modeling ALS with Regionally-Specific Human Pluripotent Stem Cell-Derived Astrocytes and Neurons
Related Videos
0 Views
Last updated: 29 August 2026